3NT Medical
Private Company
Total funding raised: $1.8M
Overview
3NT Medical is a private, commercial-stage medical device company targeting the otolaryngology market with its innovative single-use endoscope platform. The company's products are designed to address the unique anatomical and procedural needs of ENT surgery, aiming to improve sterility, usability, and cost-effectiveness compared to traditional reusable scopes. With a lean management team and products in select markets, 3NT is in a growth phase, expanding its commercial footprint. The company faces competition from established endoscopic giants and must navigate regulatory pathways and market adoption challenges.
Technology Platform
Design and manufacture of sterile, single-use digital endoscopes purpose-built for otolaryngology anatomy and procedures.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
3NT competes in the ENT endoscopy market against giants like Stryker (ENT division), Karl Storz, and Olympus, which offer reusable scope systems. It also competes with emerging companies in the single-use endoscope space, such as Ambu (though more general), and other specialists. Its differentiation is its exclusive focus on ENT-specific design.